SDIC
MRNA icon

South Dakota Investment Council’s Moderna MRNA Stock Holding History

South Dakota Investment Council’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.09M Sell
58,371
-41,181
-41% -$2.13M 0.07% 226
2026
Q1 		$5.06M Sell
99,552
-69,478
-41% -$3.24M 0.1% 187
2025
Q4 		$4.99M Sell
169,030
-46,000
-21% -$1.25M 0.09% 185
2025
Q3 		$5.55M Sell
215,030
-9,400
-4% -$262K 0.11% 178
2025
Q2 		$6.19M Sell
224,430
-15,600
-6% -$411K 0.12% 170
2025
Q1 		$6.8M Sell
240,030
-59,369
-20% -$2.11M 0.14% 150
2024
Q4 		$12.4M Buy
299,399
+11,500
+4% +$550K 0.25% 82
2024
Q3 		$19.2M Buy
287,899
+75,642
+36% +$6.94M 0.38% 49
2024
Q2 		$25.2M Sell
212,257
-906
-0.4% -$115K 0.52% 29
2024
Q1 		$22.7M Buy
213,163
+1,600
+0.8% +$161K 0.47% 40
2023
Q4 		$21M Buy
211,563
+44,779
+27% +$3.77M 0.45% 37
2023
Q3 		$17.2M Buy
166,784
+94,540
+131% +$10.5M 0.39% 43
2023
Q2 		$8.78M Buy
72,244
+63,130
+693% +$8.42M 0.18% 122
2023
Q1 		$1.4M Hold
9,114
– – 0.03% 415
2022
Q4 		$1.64M Hold
9,114
– – 0.04% 369
2022
Q3 		$1.08M Hold
9,114
– – 0.03% 424
2022
Q2 		$1.3M Hold
9,114
– – 0.03% 389
2022
Q1 		$1.57M Buy
9,114
+5,514
+153% +$928K 0.03% 366
2021
Q4 		$914K Buy
+3,600
New +$1.05M 0.02% 482

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

South Dakota Investment Council's MRNA Position: Q2 2026 in Review

South Dakota Investment Council reduced its Moderna (MRNA) stake by 41% in Q2 2026, selling an estimated $2.13M and leaving 58,371 shares worth $4.09M. The position accounts for 0.07% of the portfolio, ranked #226.

South Dakota Investment Council first reported a position in MRNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $25.2M in Q2 2024. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • South Dakota Investment Council held 58,371 shares of Moderna worth $4.09M as of Q2 2026.
  • South Dakota Investment Council sold 41,181 Moderna shares in Q2 2026, an estimated $2.13M.
  • Moderna made up 0.07% of South Dakota Investment Council's portfolio in Q2 2026, its #226 holding.
  • South Dakota Investment Council first reported a position in Moderna in Q4 2021 and has held it in 19 quarters since.
  • South Dakota Investment Council's Moderna position peaked at $25.2M in Q2 2024.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on South Dakota Investment Council's 13F filing for Q2 2026, filed 11 Aug 2026.